The impact of cataract, and its surgical removal, on measures of macular pigment using the Heidelberg spectralis HRA+OCT multicolor device

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 6, 2016, Pages 2552-2563

  Akuffo, Kwadwo Owusu ^a   Nolan, John M ^a   Stack, Jim ^a   Power, Rebecca ^a   Kirwan, Clare ^a,b   Moran, Rachel ^a   Corcoran, Laura ^a   Owens, Niamh ^a   Beatty, Stephen ^a,b  

^a South East Technological University   (Ireland)

^b Institute of Eye Surgery   (Ireland)

Author keywords

Agreement; Cataract; Cataract surgery; Concordance correlation coefficient; Fundus autofluorescence; Lutein; Macular pigment; Macular pigment optical density; Meso zeaxanthin; Optical coherence tomography; Phacoemulsification; Spectralis; Tecnis IOL; Visual acuity; Zeaxanthin

Indexed keywords

CAROTENOID; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; BLOOD ANALYSIS; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA OPACITY; DISEASE SEVERITY ASSESSMENT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LENS IMPLANTATION; MALE; MYDRIASIS; NUTRITIONAL ASSESSMENT; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OPTICAL DENSITY; PHACOEMULSIFICATION; PRIORITY JOURNAL; QUESTIONNAIRE; SLIT LAMP; SUBCAPSULAR CATARACT; VISUAL ACUITY; DEVICES; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; FOLLOW UP; METABOLISM; MIDDLE AGED; PHOTOMETRY; REPRODUCIBILITY; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CATARACT; CATARACT EXTRACTION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MACULAR PIGMENT; MALE; MIDDLE AGED; PHOTOMETRY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84966430733     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.16-19141     Document Type: Article

References (36)

1. Hirsch J, Curcio CA. The spatial resolution capacity of human foveal retina. Vis Res. 1989;29:1095-1101.
2. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. 1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660-673.
3. Bone RA, Landrum JT, Cains A. Optical-density spectra of the macular pigment in vivo and in vitro. Vis Res. 1992;32:105-110.
4. Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys. 1999;371:301-307.
5. Li B, Ahmed F, Bernstein PS. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys. 2010;504:56-60.
6. Wrona M, Rozanowska M, Sarna T. Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. Free Radic Biol Med. 2004;36:1094-1101.
7. Tian Y, Kijlstra A, van der Veen RL, Makridaki M, Murray IJ, Berendschot TT. Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels. Acta Ophthalmol. 2015;93:141-145.
8. Tian Y, Kijlstra A, van der Veen RL, Makridaki M, Murray IJ, Berendschot TT. The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d. PLoS One. 2013;8:e73387.
9. Li SY, Fung FK, Fu ZJ, Wong D, Chan HH, Lo AC. Antiinflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studies. Invest Ophthalmol Vis Sci. 2012;53:5976-5984.
10. Firdous AP, Kuttan G, Kuttan R. Anti-inflammatory potential of carotenoid meso-zeaxanthin and its mode of action. Pharm Biol. 2015;53:961-967.
11. Liu R, Wang T, Zhang B, et al. Lutein and zeaxanthin supplementation and association with visual function in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2015;56:252-258.
12. Akuffo KO, Nolan JM, Howard AN, et al. Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration. Eye (Lond). 2015;29:902-912.
13. Ma L, Yan SF, Huang YM, et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology. 2012;119: 2290-2297.
14. Loughman J, Nolan JM, Howard AN, Connolly E, Meagher K, Beatty S. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci. 2012;53:7871-7880.
15. Hammond BR, Fletcher LM, Roos F, Wittwer J, Schalch W. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Invest Ophthalmol Vis Sci. 2014;55:8583-8589.
16. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005-2015.
17. Bone RA, Landrum JT. Heterochromatic flicker photometry. Arch Biochem Biophys. 2004;430:137-142.
18. Delori FC. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys. 2004;430:156-162.
19. Wooten BR, Hammond BR. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optom Vis Sci. 2005;82:378-386.
20. Stringham JM, Hammond BR, Nolan JM, et al. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res. 2008;87:445-453.
21. Dennison JL, Stack J, Beatty S, Nolan JM. Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. Exp Eye Res. 2013;116:190-198.
22. Akuffo KO, Beatty S, Stack J, et al. Concordance of macular pigment measurement using customized heterochromatic flicker photometry and fundus autofluorescence in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56: 8207-8214.
23. Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K. Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci. 2011;52:927-932.
24. Akuffo KO, Beatty S, Stack J, et al. Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. Ophthalmic Epidemiol. 2014;21:111-123.
25. Nolan JM, Loskutova E, Howard A, et al. The impact of supplemental macular carotenoids in Alzheimer’s disease: a randomized clinical trial. J Alzheimers Dis. 2015;44:1157-1169.
26. Nolan JM, Loskutova E, Howard AN, et al. Macular pigment, visual function, and macular disease among subjects with Alzheimer’s disease: an exploratory study. J Alzheimers Dis. 2014;42:1191-1202.
27. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
28. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci. 2009;50:3432-3437.
29. Charalampidou S, Loughman J, Nolan J, et al. Prognostic indicators and outcome measures for surgical removal of symptomatic nonadvanced cataract. Arch Ophthalmol. 2011; 129:1155-1161.
30. Kirwan C, Nolan JM, Stack J, Moore TC, Beatty S. Determinants of patient satisfaction and function related to vision following cataract surgery in eyes with no visually consequential ocular co-morbidity. Graefes Arch Clin Exp Ophthalmol. 2015;253: 1735-1744.
31. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
32. Lin L, Hedayat AS, Wu W. Statistical Tools for Measuring Agreement. New York: Springer; 2012.
33. You QS, Bartsch DG, Espina M, et al. Reproducibility of macular pigment optical density measurement by twowavelength autofluorescence in a clinical setting [published online ahead of print December 11, 2015]. Retina. doi:10.1097/IAE.0000000000000893.
34. Liew SH, Gilbert CE, Spector TD, et al. Central retinal thickness is positively correlated with macular pigment optical density. Exp Eye Res. 2006;82:915-920.
35. Norren DV, Vos JJ. Spectral transmission of the human ocular media. Vis Res. 1974;14:1237-1244.
36. Saeed A, Guerin M, Khan I, et al. Deferral of first review after uneventful phacoemulsification cataract surgery until 2 weeks: randomized controlled study. J Cataract Refract Surg. 2007;33:1591-1596.